Team:ZJU-China/models.htm

From 2012.igem.org

(Difference between revisions)
 
(4 intermediate revisions not shown)
Line 92: Line 92:
   text-decoration: underline;
   text-decoration: underline;
}
}
 +
/* Bottom Environment (origin item) */
/* Bottom Environment (origin item) */
Line 118: Line 119:
{
{
   font-family: Arial, sans-serif;
   font-family: Arial, sans-serif;
 +
  font-size:16px;
   color: black;
   color: black;
   margin: 0;
   margin: 0;
   padding: 0;
   padding: 0;
 +
}
 +
 +
/********************modified by MQ***************/
 +
p.fig{
 +
  color: #573D01;
 +
  padding: 15px 15px;
 +
  font-size: 15.5px;
 +
  font-family: "Calibri","sans-serif";
 +
  align: justify;
 +
}
 +
p.ref{
 +
  color: black;
 +
  padding: 15px 15px;
 +
  font-size: 15.5px;
 +
  font-family: "Calibri","sans-serif";
 +
  align: justify;
 +
}
 +
b.orange{
 +
  color: #FF8000;
 +
  font-style:italic;
 +
}
 +
.projectNav a {
 +
font-size: 18px;
 +
font-weight: bold;
 +
padding: 1px 5px;
}
}
Line 287: Line 314:
<div class="projectNav">
<div class="projectNav">
-
<p align="justify">In this year’s project, we try to make reasonable design of riboscaffolds by ourselves. Due to the current experimental conditions, we could not know what exactly happens to our riboscaffolds in the cell. Its folding process, binding with proteins and ligand, and the allosteric transition are of interests, since these are considerations for a reasonable design. Luckily, we have simulation tools for molecular modeling which can provide hints about what may happen theoretically in the intracellular environment. Although molecular modeling is often considered as professional work in which knowledge of different disciplines such as biology, physics, chemistry, mathematics and computer science as well as previous experience all contribute to good results, our team is willing to take a step in this field and get preliminary results.</p>
+
<p align="justify">In this year’s project, we try to make <b class="orange">reasonable design</b> of riboscaffolds by ourselves. Due to the current experimental conditions, we could not know what exactly happens to our riboscaffolds in the cell. Its folding process, binding with proteins and ligand, and the allosteric transition are of interests, since these are considerations for a reasonable design. Luckily, we have <b class="orange">simulation tools</b> for molecular modeling which can provide hints about <b class="orange">what may happen theoretically in the intracellular environment</b>. Although molecular modeling is often considered as professional work in which knowledge of different disciplines such as biology, physics, chemistry, mathematics and computer science as well as previous experience all contribute to good results, our team is willing to take a step in this field and get preliminary results.</p>
<p align="justify">&nbsp;</p>
<p align="justify">&nbsp;</p>
<div class="projectNavFloat">
<div class="projectNavFloat">
-
<a target="brainFrame" href="https://2012.igem.org/Team:ZJU-China/model_s1_1.htm">1. RNA folding and 3D Structures</a>
+
<a target="brainFrame" href="https://2012.igem.org/Team:ZJU-China/model_s1_1.htm" style="text-decoration:none">1. RNA folding and 3D Structures</a>
<br>
<br>
-
<a target="brainFrame" href="https://2012.igem.org/Team:ZJU-China/model_s1_2.htm">2. Docking</a>
+
<a target="brainFrame" href="https://2012.igem.org/Team:ZJU-China/model_s1_2.htm" style="text-decoration:none">2. Docking</a>
-
<br>
+
-
<a target="brainFrame" href="https://2012.igem.org/Team:ZJU-China/model_s1_3.htm">3. Molecular Dynamics</a>
+
</div><!-- end .projectNavFloat -->
</div><!-- end .projectNavFloat -->
<div class="projectNavFloat">
<div class="projectNavFloat">
-
<a target="brainFrame" href="https://2012.igem.org/Team:ZJU-China/model_s1_4.htm">4. References</a>
+
<a target="brainFrame" href="https://2012.igem.org/Team:ZJU-China/model_s1_3.htm" style="text-decoration:none">3. Molecular Dynamics</a>
 +
<br>
 +
<a target="brainFrame" href="https://2012.igem.org/Team:ZJU-China/model_s1_4.htm" style="text-decoration:none">4. References</a>
</div><!-- end .projectNavFloat -->
</div><!-- end .projectNavFloat -->
Line 318: Line 345:
<div class="projectNavFloat">
<div class="projectNavFloat">
-
<a target="brainFramei" href="https://2012.igem.org/Team:ZJU-China/model_s2_1.htm">1. Preparation</a>
+
<a target="brainFramei" href="https://2012.igem.org/Team:ZJU-China/model_s2_1.htm" style="text-decoration:none">1. Preparation</a>
<br>
<br>
-
<a target="brainFramei" href="https://2012.igem.org/Team:ZJU-China/model_s2_2.htm">2. A small scale simulation</a>
+
<a target="brainFramei" href="https://2012.igem.org/Team:ZJU-China/model_s2_2.htm" style="text-decoration:none">2. A small scale simulation</a>
-
<br>
+
-
<a target="brainFramei" href="https://2012.igem.org/Team:ZJU-China/model_s2_3.htm">3. A large scale simulation</a>
+
</div><!-- end .projectNavFloat -->
</div><!-- end .projectNavFloat -->
<div class="projectNavFloat">
<div class="projectNavFloat">
-
<a target="brainFramei" href="https://2012.igem.org/Team:ZJU-China/model_s2_4.htm">4. Additional effects</a>
+
<a target="brainFramei" href="https://2012.igem.org/Team:ZJU-China/model_s2_3.htm" style="text-decoration:none">3. A large scale simulation</a>
 +
<br>
 +
<a target="brainFramei" href="https://2012.igem.org/Team:ZJU-China/model_s2_4.htm" style="text-decoration:none">4. Additional effects</a>
</div><!-- end .projectNavFloat -->
</div><!-- end .projectNavFloat -->
Line 346: Line 373:
<p align="justify">There are two aptamers on the RNA scaffold named aptamer1 (A1) and aptamer2 (A2). Aptamer1 is binding with MS2 and aptamer2 is binding with PP7. Before establishing the model, we declare some assumptions.</p>
<p align="justify">There are two aptamers on the RNA scaffold named aptamer1 (A1) and aptamer2 (A2). Aptamer1 is binding with MS2 and aptamer2 is binding with PP7. Before establishing the model, we declare some assumptions.</p>
<p align="justify">&nbsp;</p>
<p align="justify">&nbsp;</p>
-
<p align="justify">1.After mixing the RNA scaffold, MS2 and PP7, no RNA, MS2 and PP7 are added to the solution or removed from the solution.</p>
+
<p class="ref" align="justify" >1. After mixing the RNA scaffold, MS2 and PP7, no RNA, MS2 and PP7 are added to the solution or removed from the solution.</br>
-
<p align="justify">&nbsp;</p>
+
2. MS2 would not bind with aptamer2 and PP7 would not bind with aptamer1.</br>
-
<p align="justify">2.MS2 would not bind with aptamer2 and PP7 would not bind with aptamer1.</p>
+
3. The binding of MS2 to aptamer1 and the binding of PP7 to aptamer2 are independent with each other. The binding of one would not affect the binding of the other.</p>
-
<p align="justify">&nbsp;</p>
+
-
<p align="justify">3.The binding of MS2 to aptamer1 and the binding of PP7 to aptamer2 are independent with each other. The binding of one would not affect the binding of the other.</p>
+
<p align="justify">&nbsp;</p>
<p align="justify">&nbsp;</p>
<p align="justify">Symbols and Parameters Declaration</p>
<p align="justify">Symbols and Parameters Declaration</p>
Line 396: Line 421:
<p align="justify">`[MS2A1_0]=0`</P>
<p align="justify">`[MS2A1_0]=0`</P>
<p align="justify">`[PP7A2_0]=0`</p>
<p align="justify">`[PP7A2_0]=0`</p>
-
 
+
</br>
<h2>Equilibrium analysis</h2>
<h2>Equilibrium analysis</h2>
<p align="justify">&nbsp;</p>
<p align="justify">&nbsp;</p>
Line 407: Line 432:
<p align="justify">&nbsp;</p>
<p align="justify">&nbsp;</p>
<p align="justify">The results are shown as follows:</p>
<p align="justify">The results are shown as follows:</p>
-
<div><img src="http://www.jiajunlu.com/igem/zju_model3_1.jpg"></div>
+
<div class="floatC"><img src="http://www.jiajunlu.com/igem/zju_model3_1.jpg"></div>
-
<p align="justify">Figure 1. The fraction of aptamer1-MS2 complex and the fraction of aptamer2-PP7 complex are increasing and finally reach equilibrium. </p>
+
<p class="fig" align="justify"><b>Fig 1.</b> The fraction of aptamer1-MS2 complex and the fraction of aptamer2-PP7 complex are increasing and finally reach equilibrium. </p>
<p align="justify">&nbsp;</p>
<p align="justify">&nbsp;</p>
<p align="justify">As we mentioned above, the binding of MS2 to aptamer1 and the binding of PP7 to aptamer2 are independent with each other. The binding of one would not affect the binding of the other. From probability theoretical perspective, the fraction of RNA scaffold binding with both MS2 and PP7 is equal to the fraction of RNA scaffold binding with MS2 multiply the fraction of RNA scaffold binding with PP7. The RNA scaffold binding with both MS2 and PP7 is what we need to improve the reaction rate of pathways. </p>
<p align="justify">As we mentioned above, the binding of MS2 to aptamer1 and the binding of PP7 to aptamer2 are independent with each other. The binding of one would not affect the binding of the other. From probability theoretical perspective, the fraction of RNA scaffold binding with both MS2 and PP7 is equal to the fraction of RNA scaffold binding with MS2 multiply the fraction of RNA scaffold binding with PP7. The RNA scaffold binding with both MS2 and PP7 is what we need to improve the reaction rate of pathways. </p>
<p align="justify">&nbsp;</p>
<p align="justify">&nbsp;</p>
<h2>References</h2>
<h2>References</h2>
-
<p align="justify">[1] Ajish S. R. Potty, Katerina Kourentzi, Han Fang, George W. Jackson, Xing Zhang, Glen B. Legge, Richard C. Willson. Biophysical Characterization of DNA Aptamer Interactions with Vascular Endothelial Growth Factor. 2008.</p>
+
<p class="ref" align="justify">[1] Ajish S. R. Potty, Katerina Kourentzi, Han Fang, George W. Jackson, Xing Zhang, Glen B. Legge, Richard C. Willson. Biophysical Characterization of DNA Aptamer Interactions with Vascular Endothelial Growth Factor. 2008.</p>
</div>
</div>
</div><!-- end .acc_container -->
</div><!-- end .acc_container -->

Latest revision as of 03:14, 27 October 2012

MODELS

01 Molecular Modeling

02 Scaffold or Non-scaffold

03 Binding analysis